Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-76fb5796d-9pm4c Total loading time: 0 Render date: 2024-04-26T08:44:10.178Z Has data issue: false hasContentIssue false

15 - Unusual Types of α Thalassemia

from SECTION THREE - α THALASSEMIA

Published online by Cambridge University Press:  03 May 2010

Martin H. Steinberg ,
Bernard G. Forget ,
Douglas R. Higgs  and
David J. Weatherall
By
Douglas R. Higgs ,
Veronica J. Buckle ,
Richard Gibbons  and
David Steensma
Martin H. Steinberg
Affiliation:
Boston University
Bernard G. Forget
Affiliation:
Yale University, Connecticut
Douglas R. Higgs
Affiliation:
MRC Institute of Molecular Medicine, University of Oxford
David J. Weatherall
Affiliation:
Albert Einstein College of Medicine, New York
Get access

Summary

INTRODUCTION

In this chapter we describe three relatively rare, clinically complex syndromes in which the occurrence of α thalassemia provided the clue to understanding the molecular basis of each condition. These conditions exemplify the important interplay between clinical observation and human molecular genetics. Two of these syndromes (ATR-16 [OMIM: 141750] and ATR-X [OMIM: 301040]) in which α thalassemia is associated with multiple developmental abnormalities (including mental retardation, MR) are inherited. The third condition (ATMDS [OMIM: 300448]) is an acquired disorder in which α thalassemia appears for the first time in the context of myelodysplasia.

α THALASSEMIA ASSOCIATED WITH MENTAL RETARDATION AND DEVELOPMENTAL ABNORMALITIES

The rare association of α thalassemia and mental retardation (MR) was recognized more than 25 years ago by Weatherall and colleagues. It was known that α thalassemia arises when there is a defect in the synthesis of the α-globin chains of adult hemoglobin (HbA, α2β2). When these authors encountered three mentally retarded children with α thalassemia and a variety of developmental abnormalities, their interest was stimulated by the unusual nature of the α thalassemia. The children were of northern European origin, where α thalassemia is uncommon, and although one would have expected to find clear signs of this inherited anemia in their parents, it appeared to have arisen de novo in the affected offspring. It was thought that the combination of α thalassemia with MR (ATR), and the associated developmental abnormalities represented a new syndrome and that a common genetic defect might be responsible for the diverse clinical manifestations.

Type
Chapter
Information
Disorders of Hemoglobin
Genetics, Pathophysiology, and Clinical Management
 , pp. 296 - 320
Publisher: Cambridge University Press
Print publication year: 2009

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Weatherall, DJ, Higgs, DR, Bunch, C, et al. Hemoglobin H disease and mental retardation. A new syndrome or a remarkable coincidence?N Engl J Med. 1981;305:607–612.CrossRefGoogle ScholarPubMed
Wilkie, AOM, Buckle, VJ, Harris, PC, et al. Clinical features and molecular analysis of the α thalassaemia/mental retardation syndromes. I. Cases due to deletions involving chromosome band 16p13.3. Am J Hum Genet. 1990;46:1112–1126.Google ScholarPubMed
Wilkie, AOM, Zeitlin, HC, Lindenbaum, RH, et al. Clinical features and molecular analysis of the α thalassemia/mental retardation syndromes. II. Cases without detectable abnormality of the α globin complex. Am J Hum Genet. 1990;46: 1127–1140.Google Scholar
Schmickel, RD. Contiguous gene syndromes: a component of recognizable syndromes. J Pediatr. 1986;109:231–241.CrossRefGoogle ScholarPubMed
Callen, DF, Hyland, VJ, Baker, EG, et al. Mapping the short arm of human chromosome 16. Genomics. 1989;4:348–354.CrossRefGoogle ScholarPubMed
Neidengard, L, Sparkes, RS. Ring chromosome 16. Hum Genet. 1981;59:175–177.CrossRefGoogle ScholarPubMed
Quintana, A, Sordo, MT, Estevez, C, Ludena, MC, San Roman, C. 16 Ring chromosome. Clin Genet. 1983;23:243.Google Scholar
Buckle, VJ, Higgs, DR, Wilkie, AOM, Super, M, Weatherall, DJ. Localisation of human α globin to 16p13.3-pter. J Med Genet. 1988;25:847–849.CrossRefGoogle Scholar
Lamb, J, Wilkie, AOM, Harris, PC, et al. Detection of breakpoints in submicroscopic chromosomal translocation, illustrating an important mechanism for genetic disease. Lancet. 1989;ii:819–824.CrossRefGoogle Scholar
Buckle, VJ, Kearney, L. New methods in cytogenetics. Curr Opin Genet Dev. 1994;4:374–382.CrossRefGoogle ScholarPubMed
Brown, J, Saracoglu, K, Uhrig, S, Speicher, MR, Eils, R, Kearney, L. Subtelomeric chromosome rearrangements are detected using an innovative 12-color FISH assay (M-TEL). Nat Med. 2001;7:497–501.CrossRefGoogle Scholar
Price, TS, Regan, R, Mott, R, et al. SW-ARRAY:a dynamic programming solution for the identification of copy-number changes in genomic DNA using array comparative genome hybridization data. Nucl Acids Res. 2005;33:3455–3464.CrossRefGoogle ScholarPubMed
Redon, R, Ishikawa, S, Fitch, KR, et al. Global variation in copy number in the human genome. Nature. 2006;444:444–454.CrossRefGoogle ScholarPubMed
Colella, S, Yau, C, Taylor, JM, et al. QuantiSNP: an Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data. Nucl Acids Res. 2007;35:2013–2025.CrossRefGoogle ScholarPubMed
Harteveld, CL, Kriek, M, Bijlsma, EK, et al. Refinement of the genetic cause of ATR-16. Hum Genet. 2007;122:283–292.CrossRefGoogle ScholarPubMed
Harteveld, CL, Voskamp, A, Phylipsen, M, et al. Nine unknown rearrangements in 16p13.3 and 11p15.4 causing alpha- and beta-thalassaemia characterised by high resolution multiplex ligation-dependent probe amplification. J Med Genet. 2005;42:922–931.CrossRefGoogle ScholarPubMed
Lamb, J, Harris, PC, Wilkie, AOM, Wood, WG, Dauwerse, JG, Higgs, DR. De novo truncation of chromosome 16p and healing with (TTAGGG)n in the α-thalassemia/mental retardation syndrome (ATR-16). Am J Hum Genet. 1993;52:668–676.Google Scholar
Daniels, RJ, Peden, JF, Lloyd, C, et al. Sequence, structure and pathology of the fully annotated terminal 2 Mb of the short arm of human chromosome 16. Hum Mol Genet. 2001;10:339–352.CrossRefGoogle ScholarPubMed
Horsley, SW, Daniels, RJ, Anguita, E, et al. Monosomy for the most telomeric, gene-rich region of the short arm of human chromosome 16 causes minimal phenotypic effects. Eur J Hum Genet. 2001;9:217–225.CrossRefGoogle ScholarPubMed
,European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14 kb transcript and lies within a duplicated region on chromosome 16. Cell. 1994;77:881–894.CrossRefGoogle Scholar
Vogel, F, Motulsky, AG. Human Genetics. Problems and Approaches. 2nd ed. Berlin: Springer-Verlag; 1986.CrossRefGoogle Scholar
Hall, JG. Genomic imprinting: review and relevance to human diseases. Am J Hum Genet. 1990;46:857–873.Google ScholarPubMed
Schneider, AS, Bischoff, FZ, McCaskill, C, Coady, ML, Stopfer, JE, Shaffer, LG. Comprehensive 4-year follow-up on a case of maternal heterodisomy for chromosome 16. Am J Med Genet. 1996;66:204–208.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Fisher, E, Scambler, P. Human haploinsufficiency – one for sorrow, two for joy. Nat Genet. 1994;7:5–7.CrossRefGoogle ScholarPubMed
Pfeifer, D, Poulat, F, Holinski-Feder, E, Kooy, F, Scherer, G. The SOX8 gene is located within 700 kb of the tip of chromosome 16p and is deleted in a patient with ATR-16 syndrome. Genomics. 2000;63:108–116.CrossRefGoogle Scholar
Flint, J, Wilkie, AOM, Buckle, VJ, Winter, RM, Holland, AJ, McDermid, HE. The detection of subtelomeric chromosomal rearrangements in idiopathic mental retardation. Nat Genet. 1995;9:132–140.CrossRefGoogle ScholarPubMed
Wilkie, AOM, Pembrey, ME, Gibbons, RJ, et al. The non-deletion type of α thalassaemia/mental retardation: a recognisable dysmorphic syndrome with X-linked inheritance. J Med Genet. 1991;28:724.CrossRefGoogle ScholarPubMed
Gibbons, RJ, Wilkie, AOM, Weatherall, DJ, Higgs, DR. A newly defined X linked mental retardation syndrome associated with α thalassaemia. J Med Genet. 1991;28:729–733.CrossRefGoogle ScholarPubMed
Carpenter, NJ, Qu, Y, Curtis, M, Patil, SR. X-linked mental retardation syndrome with characteristic “coarse” facial appearance, brachydactyly, and short stature maps to proximal Xq. Am J Med Genet. 1999;85:230–235.3.0.CO;2-O>CrossRefGoogle ScholarPubMed
Guerrini, R, Shanahan, JL, Carrozzo, R, Bonanni, P, Higgs, DR, Gibbons, RJ. A nonsense mutation of the ATRX gene causing mild mental retardation and epilepsy. Ann Neurol. 2000;47:117–121.3.0.CO;2-A>CrossRefGoogle ScholarPubMed
Yntema, HG, Poppelaars, FA, Derksen, E, et al. Expanding phenotype of XNP mutations: mild to moderate mental retardation. Am J Med Genet. 2002;110:243–247.CrossRefGoogle ScholarPubMed
Abidi, FE, Cardoso, C, Lossi, AM, et al. Mutation in the 5′ alternatively spliced region of the XNP/ATR-X gene causes Chudley-Lowry syndrome. Eur J Hum Genet. 2005;13:176–183.CrossRefGoogle ScholarPubMed
Wada, T, Gibbons, RJ. ATR-X syndrome. In: Fisch, GS, ed. Genetics and Genomics of Neurobehavioral Disorders. Totowa, NJ: Humana Press; 2003:309–334.CrossRefGoogle Scholar
Kurosawa, K, Akatsuka, A, Ochiai, Y, Ikeda, J, Maekawa, K. Self-induced vomiting in X-linked α-thalassemia/mental retardation syndrome. Am J Med Genet. 1996;63:505–506.CrossRefGoogle ScholarPubMed
Wada, T, Nakamura, M, Matsushita, Y, et al. [Three Japanese children with X-linked alpha-thalassemia/mental retardation syndrome (ATR-X)]. No To Hattatsu. 1998;30:283–289.Google Scholar
McPherson, E, Clemens, M, Gibbons, RJ, Higgs, DR. X-linked alpha thalassemia/mental retardation (ATR-X) syndrome. A new kindred with severe genital anomalies and mild hematologic expression. Am J Med Genet. 1995;55:302–306.CrossRefGoogle ScholarPubMed
Gibbons, RJ, Brueton, L, Buckle, VJ, et al. The clinical and hematological features of the X-linked α thalassemia/mental retardation syndrome (ATR-X). Am J Med Genet. 1995; 55:288–299.CrossRefGoogle Scholar
Martucciello, G, Lombardi, L, Savasta, S, Gibbons, RJ. The gastrointestinal phenotype of ATR-X syndrome. Am J Med Genet. 2006;140:1172–1176.CrossRefGoogle ScholarPubMed
Villard, L, Gecz, J, Mattel, JF, et al. XNP mutation in a large family with Juberg-Marsidi syndrome. Nat Genet. 1996;12:359–360.CrossRefGoogle Scholar
Villard, L, Lacombe, D, Fontes, M. A point mutation in the XNP gene, associated with an ATR-X phenotype without α-thalassemia. Eur J Hum Genet. 1996;4:316–320.CrossRefGoogle ScholarPubMed
Donnai, D, Clayton-Smith, J, Gibbons, RJ, Higgs, DR. The non-deletion α thalassaemia/mental retardation syndrome. Further support for X linkage. J Med Genet. 1991;28:742–745.CrossRefGoogle ScholarPubMed
Gibbons, RJ, Suthers, GK, Wilkie, AOM, Buckle, VJ, Higgs, DR. X-linked α thalassemia/mental retardation (ATR-X) syndrome: Localisation to Xq12-21.31 by X-inactivation and linkage analysis. Am J Hum Genet. 1992;51:1136–1149.Google Scholar
Garrick, D, Sharpe, JA, Arkell, R, et al. Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues. PLoS Genet. 2006;2:e58.CrossRefGoogle ScholarPubMed
Muers, MR, Sharpe, JA, Garrick, D, et al. Defining the cause of skewed X-chromosome inactivation in X-linked mental retardation by use of a mouse model. Am J Hum Genet. 2007;80:1138–1149.CrossRefGoogle ScholarPubMed
Gecz, J, Pollard, H, Gonzalez, G, et al. Cloning and expression of the murine homologue of a putative human X-linked nuclear protein gene closely linked to PGK1 in Xq13.3. Hum Mol Genet. 1994;3:39–44.CrossRefGoogle ScholarPubMed
Gibbons, RJ, Picketts, DJ, Villard, L, Higgs, DR. Mutations in a putative global transcriptional regulator cause X-linked mental retardation with α-thalassemia (ATR-X syndrome). Cell. 1995;80:837–845.CrossRefGoogle Scholar
Picketts, DJ, Higgs, DR, Bachoo, S, Blake, DJ, Quarrell, OWJ, Gibbons, RJ. ATRX encodes a novel member of the SNF2 family of proteins: mutations point to a common mechanism underlying the ATR-X syndrome. Hum Mol Genet. 1996;5:1899–1907.CrossRefGoogle ScholarPubMed
Garrick, D, Samara, V, McDowell, TL, et al. A conserved truncated isoform of the ATR-X syndrome protein lacking the SWI/SNF-homology domain. Gene. 2004;326:23–34.CrossRefGoogle ScholarPubMed
Gibbons, RJ, Bachoo, S, Picketts, DJ, et al. Mutations in a transcriptional regulator (hATRX) establish the functional significance of a PHD-like domain. Nat Genet. 1997;17:146–148.CrossRefGoogle Scholar
Argentaro, A, Yang, JC, Chapman, L, et al. Structural consequences of disease-causing mutations in the ATRX-DNMT3-DNMT3L (ADD) domain of the chromatin-associated protein ATRX. Proc Natl Acad Sci USA. 2007;104:11939–11944.CrossRefGoogle ScholarPubMed
Bienz, M. The PHD finger, a nuclear protein-interaction domain. Trends Biochem Sci. 2006;31:35–40.CrossRefGoogle ScholarPubMed
Cardoso, C, Lutz, Y, Mignon, C, et al. ATR-X mutations cause impaired nuclear location and altered DNA binding properties of the XNP/ATR-X protein. J Med Genet. 2000;37:746–751.CrossRefGoogle ScholarPubMed
Picketts, DJ, Tastan, AO, Higgs, DR, Gibbons, RJ. Comparison of the human and murine ATRX gene identifies highly conserved, functionally important domains. Mammal Genome. 1998;9:400–403.CrossRefGoogle ScholarPubMed
Carlson, M, Laurent, BC. The SNF/SWI family of global transcriptional activators. Curr Opin Cell Biol. 1994;6:396–402.CrossRefGoogle ScholarPubMed
Gibbons, RJ, Wada, T, Fisher, C, et al. Mutations in the chromatin associated protein ATRX. Hum Mutat. 2008:29:796–802.CrossRefGoogle ScholarPubMed
Howard, MT, Malik, N, Anderson, CB, Voskuil, JL, Atkins, JF, Gibbons, RJ. Attenuation of an amino-terminal premature stop codon mutation in the ATRX gene by an alternative mode of translational initiation. J Med Genet. 2004;41:951–956.CrossRefGoogle ScholarPubMed
McDowell, TL, Gibbons, RJ, Sutherland, H, et al. Localization of a putative transcriptional regulator (ATRX) at pericentromeric heterochromatin and the short arms of acrocentric chromosomes. Proc Natl Acad Sci USA. 1999;96:13983–13988.CrossRefGoogle ScholarPubMed
Badens, C, Lacoste, C, Philip, N, et al. Mutations in PHD-like domain of the ATRX gene correlate with severe psychomotor impairment and severe urogenital abnormalities in patients with ATRX syndrome. Clin Genet. 2006;70:57–62.CrossRefGoogle ScholarPubMed
Ion, A, Telvi, L, Chaussain, JL, et al. A novel mutation in the putative DMA Helicase XH2 is responsible for male-to-female sex reversal associated with an atypical form of the ATR-X syndrome. Am J Hum Genet. 1996;58:1185–1191.Google Scholar
Villard, L, Toutain, A, Lossi, A-M, et al. Splicing mutation in the ATR-X gene can lead to a dysmorphic mental retardation phenotype without α-thalassemia. Am J Hum Genet. 1996;58:499–505.Google ScholarPubMed
Stayton, CL, Dabovic, B, Gulisano, M, Gecz, J, Broccoli, V, Giovanazzi, S et al. Cloning and characterisation of a new human Xq13 gene, encoding a putative helicase. Hum Mol Genet. 1994;3:1957–1964.CrossRefGoogle Scholar
Berube, NG, Smeenk, CA, Picketts, DJ. Cell cycle-dependent phosphorylation of the ATRX protein correlates with changes in nuclear matrix and chromatin association. Hum Mol Genet. 2000;9:539–547.CrossRefGoogle ScholarPubMed
Xue, Y, Gibbons, R, Van, Z, et al. The ATRX syndrome protein forms a chromatin-remodeling complex with Daxx and localizes in promyelocytic leukemia nuclear bodies. Proc Natl Acad Sci USA. 2003;100:10635–10640.CrossRefGoogle ScholarPubMed
Gibbons, RJ, McDowell, TL, Raman, S, et al. Mutations in ATRX, encoding a SWI/SNF-like protein, cause diverse changes in the pattern of DNA methylation. Nat Genet. 2000;24:368–371.CrossRefGoogle ScholarPubMed
Douarin, B, Nielsen, AL, Gamier, JM, et al. A possible involvement of TIF1 alpha and TIF1 beta in the epigenetic control of transcription by nuclear receptors. EMBO J. 1996;15:6701–6715.Google ScholarPubMed
Kourmpuli, N, Sun, YM, Sar, S, Singh, PB, Brown, JP. Epigenetic regulation of mammalian pericentric heterochromatin in vivo by HP1. Biochem Biophys Res Commun. 2005;337:901–907.CrossRefGoogle Scholar
Nan, X, Hou, J, Maclean, A, et al. Interaction between chromatin proteins MECP2 and ATRX is disrupted by mutations that cause inherited mental retardation. Proc Natl Acad Sci USA. 2007;104:2709–2714.CrossRefGoogle ScholarPubMed
Wysocka, J, Swigut, T, Xiao, H, et al. A PHD finger of NURF couples histone H3 lysine 4 trimethylation with chromatin remodelling. Nature. 2006;442:86–90.CrossRefGoogle ScholarPubMed
Pena, PV, Davrazou, F, Shi, X, et al. Molecular mechanism of histone H3K4me3 recognition by plant homeodomain of ING2. Nature. 2006;442:100–103.CrossRefGoogle ScholarPubMed
Fuks, F, Burgers, WA, Godin, N, Kasai, M, Kouzarides, T. Dnmt3a binds deacetylases and is recruited by a sequence-specific represser to silence transcription. EMBO J. 2001;20:2536–2544.CrossRefGoogle Scholar
Tang, J, Wu, S, Liu, H, et al. A novel transcription regulatory complex containing death domain-associated protein and the ATR-X syndrome protein. J Biol Chem. 2004;279:20369–20377.CrossRefGoogle ScholarPubMed
Cardoso, C, Timsit, S, Villard, L, Khrestchatisky, M, Fontes, M, Colleaux, L. Specific interaction between the XNP/ATR-X gene product and the SET domain of the human EZH2 protein. Hum Mol Genet. 1998;7:679–684.CrossRefGoogle ScholarPubMed
Dennis, K, Fan, T, Geiman, T, Van, Q, Muegge, K. Lsh, a member of the SNF2 family, is required for genome-wide methylation. Genes Dev. 2001;15:2940–2944.CrossRefGoogle ScholarPubMed
Jeddeloh, JA, Stokes, TL, Richards, EJ. Maintenance of genomic methylation requires a SWI2/SNF2-like protein [see comments]. Nat Genet. 1999;22:94–97.CrossRefGoogle Scholar
Steensma, DP, Gibbons, RJ, Higgs, DR. Acquired α thalassemia in association with myelodysplastic syndrome and other hematologic malignancies. Blood. 2005;105:443–452.CrossRefGoogle ScholarPubMed
Bergren, WR, Sturgeon, PH. Hemoglobin H: Some Additional Findings. New York: Proceedings of the 7th International Congress in Hematology; 1960:488.Google Scholar
White, JC, Ellis, M, Coleman, PN, et al. An unstable haemoglobin associated with some cases of leukaemia. Br J Haematol. 1960;6:171–177.CrossRefGoogle ScholarPubMed
Harris, NL, Jaffe, ES, Diebold, J, et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol. 1999;17:3835–3849.CrossRefGoogle Scholar
Higgs, DR, Wood, WG, Barton, C, Weatherall, DJ. Clinical features and molecular analysis of acquired hemoglobin H disease. Am J Med. 1983;75:181–191.CrossRefGoogle ScholarPubMed
Bradley, TB, Ranney, HM. Acquired disorders of hemoglobin. Prog Hematol. 1973;8:77–98.Google ScholarPubMed
Dibenedetto, SP, Russo Mancuso, G, Di Cataldo, A, Schiliro, G. Non inherited hemoglobin anomalies. Haematologica. 1991;76:414–420.Google ScholarPubMed
Hoyle, C, Kaeda, J, Leslie, J, Luzzatto, L. Acquired beta thalassaemia trait in MDS. Br J Haematol. 1991;79:116–117.CrossRefGoogle ScholarPubMed
Weinberg, RS, Leibowitz, D, Weinblatt, ME, Kochen, J, Alter, BP. Juvenile chronic myelogenous leukaemia: the only example of truly fetal (not fetal-like) erythropoiesis. Br J Haematol. 1990;76:307–310.CrossRefGoogle ScholarPubMed
Old, J, Longley, J, Wood, WG, Clegg, JB, Weatherall, DJ. Molecular basis for acquired haemoglobin H disease. Nature. 1977;269:524–525.CrossRefGoogle ScholarPubMed
Steensma, DP, Porcher, JC, Hanson, CA, et al. Prevalence of erythrocyte haemoglobin H inclusions in unselected patients with clonal myeloid disorders. Br J Haematol. 2007;139:439–442.CrossRefGoogle ScholarPubMed
Siekmeier, R, Bierlich, A, Jaross, W. Determination of reticulocytes:three methods compared. Clin Chem Lab Med. 2000;38:245–249.CrossRefGoogle ScholarPubMed
Higgs, DR, Garrick, D, Anguita, E, et al. Understanding α-globin gene regulation: aiming to improve the management of thalassemia. Ann NY Acad Sci. 2005;1054:92–102.CrossRefGoogle ScholarPubMed
Kueh, YK. Acute lymphoblastic leukemia with brilliant cresyl blue erythrocytic inclusions-acquired hemoglobin H?N Engl J Med. 1982;307:193–194.Google ScholarPubMed
Higgs, DR, Wood, WG, Barton, C, Weatherall, DJ. Clinical features and molecular analysis of acquired HbH disease. Am J Med. 1983;75:181–191.CrossRefGoogle Scholar
Peters, RE, May, A, Jacobs, A. Increased alpha:non-alpha globin chain synthesis ratios in myelodysplastic syndromes and myeloid leukaemia. J Clin Pathol. 1986;39:1233–1235.CrossRefGoogle ScholarPubMed
Higgs, DR. Ham-Wasserman lecture: gene regulation in hematopoiesis: new lessons from thalassemia. Hematology Am Soc Hematol Edu Program. 2004:1–13.Google Scholar
Gibbons, RJ, Pellagatti, A, Garrick, D, et al. Identification of acquired somatic mutations in the gene encoding chromatin-remodeling factor ATRX in the alpha-thalassemia myelodysplasia syndrome (ATMDS). Nat Genet. 2003;34:446–449.CrossRefGoogle Scholar
Steensma, DP, Higgs, DR, Fisher, CA, Gibbons, RJ. Acquired somatic ATRX mutations in myelodysplastic syndrome associated with alpha thalassemia (ATMDS) convey a more severe hematologic phenotype than germline ATRX mutations. Blood. 2004;103:2019–2026.CrossRefGoogle Scholar
Weatherall, DJ, Higgs, DR, Clegg, JB. The molecular pathology of the alpha globin genes. Br J Cancer. 1988;9(Suppl):17–22.Google ScholarPubMed
Steensma, DP, Viprakasit, V, Hendrick, A, et al. Deletion of the alpha-globin gene cluster as a cause of acquired alpha-thalassemia in myelodysplastic syndrome. Blood. 2004;103: 1518–1520.CrossRefGoogle ScholarPubMed
Helder, J, Deisseroth, A. S1 nuclease analysis of α-globin gene expression in preleukemic patients with acquired hemoglobin H disease after transfer to mouse erythroleukemia cells. Proc Natl Acad Sci. USA. 1987;84:2387–2390.CrossRefGoogle ScholarPubMed
Gibbons, RJ, Wada, T. ATRX and X-linked α-thalassemia mental retardation syndrome. In: Epstein, CJ, Erickson, RP, Wynshaw-Boris, A, eds. Inborn Errors of Development. Oxford: Oxford University Press; 2004:747–757.Google Scholar
Nelson, ME, Thurmes, PJ, Hoyer, JD, Steensma, DP. A novel 5′ ATRX mutation with splicing consequences in acquired alpha thalassemia-myelodysplastic syndrome. Haematologica. 2005;90:1463–1470.Google ScholarPubMed
Costa, DB, Fisher, CA, Miller, KB, et al. A novel mutation in the last exon of ATRX in a patient with alpha-thalassemia myelodysplastic syndrome. Eur J Haematol. 2006;76:432–435, 53.CrossRefGoogle Scholar
Haas, PS, Schwabe, M, Fisher, C, et al. Two novel somatic mutations of the ATRX gene in female patients with acquired alpha thalassemia in myelodysplastic syndrome (ATMDS). Blood. 2006;108:A1765.Google Scholar
Gibbons, RJ, Higgs, DR. The Molecular-Clinical Spectrum of the ATR-X Syndrome. Am J Med Genet. 2000;97:204–212.3.0.CO;2-X>CrossRefGoogle ScholarPubMed
Steensma, DP, Allen, S, Gibbons, RJ, Fisher, CA, Higgs, DR. Abstract 3606: A novel splicing mutation in the gene encoding the chromatin-associated factor ATRX associated with acquired hemoglobin H disease in myelodysplastic syndrome (ATMDS). Blood. 2004;104(11):A3606.Google Scholar
Steensma, DP, Bennett, JM. The myelodysplastic syndromes: diagnosis and treatment. Mayo Clin Proc. 2006;81:104–130.CrossRefGoogle ScholarPubMed
Jones, PA, Baylin, SB. The fundamental role of epigenetic events in cancer. Nat Rev Genet. 2002;3:415–428.CrossRefGoogle Scholar
Leone, G, Teofili, L, Voso, MT, Lubbert, M. DMA methylation and demethylating drugs in myelodysplastic syndromes and secondary leukemias. Haematologica. 2002;87:1324–1341.Google Scholar
Kantarjian, H, Issa, JP, Rpsenfeld, CS, et al. Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study. Cancer. 2006;106: 1794–1803.CrossRefGoogle ScholarPubMed
Silverman, LR, Demakos, EP, Peterson, BL, et al. Randomized controlled trial of azacitidine in patients with the myelodysplastic syndrome: a study of the cancer and leukemia group B. J Clin Oncol. 2002;20:2429–2440.CrossRefGoogle ScholarPubMed
Silverman, LR. DMA methyltransferase inhibitors in myelodysplastic syndrome. Best Pract Res Clin Haematol. 2004;17:585–594.CrossRefGoogle Scholar
Lindor, NM, Valdes, MG, Wick, M, Thibodeau, SN, Jalal, S. De novo 16p deletion:ATR-16 syndrome. Am J Med Genet. 1997;72:451–454.3.0.CO;2-Q>CrossRefGoogle ScholarPubMed
Fei, YJ, Liu, JC, Walker, ELDI, Huisman, THJ. A new gene deletion involving the α2-, α1-, and θ1-globin genes in a Black family with HbH disease. Am J Hematol. 1992;39:299–303.CrossRefGoogle Scholar
Felice, AE, Cleek, MP, McKie, K, McKie, V, Huisman, THJ. The rare α-thalassemia-1 of Blacks is a ςα-thalassemia-1 associated with deletion of all α- and ς-globin genes. Blood. 1984;63:1253–1257.Google ScholarPubMed
Rack, KA, Harris, PC, MacCarthy, AB, et al. Characterization of three de novo derivative chromosomes 16 by ‘reverse chromosome painting’ and molecular analysis. Am J Hum Genet. 1993;52:987–997.Google Scholar
Rönich, P, Kleihauer, E. Alpha-thalassamie mit HbH und Hb Bart's in einer deutschen Familie. Klin Wochenschrift. 1967;45:S1193–1200.CrossRefGoogle Scholar
Gallego, MS, Zelaya, G, Feliu, AS, et al. ATR-16 due to a de novo complex rearrangement of chromosome 16. Hemoglobin. 2005;29:141–150.CrossRefGoogle ScholarPubMed
Gibson, WT, Harvard, C, Qiao, Y, Somerville, MJ, Lewis, MES, Rajcan-Separovic, E. Phenotype-genotype characterization of alpha-thalassemia mental retardation syndrome due to isolated monosomy of 16p13.3. Am J Med Genet. 2008;146A:225–232.CrossRefGoogle ScholarPubMed
Kamei, M, Ades, LC, Eyre, HJ, Callen, DF, Campbell, HD. SOLH, a human homologue of the Drosophila melanogaster small optic lobes gene is deleted in ATR-16 syndrome. Appl Genom Proteom. 2002;1:65–71.Google Scholar
Villegas, A, Ropero, P, Gonzalez, FA, Anguita, E, Espinos, D. The thalassemia syndromes: molecular characterization in the Spanish population. Hemoglobin. 2001;25:273–283.CrossRefGoogle ScholarPubMed
Hjelle, B, Charache, S, Phillips, JAR. Hemoglobin H disaese and multiple congenital anomalies in a child of northern European origin. Am J Hematol. 1982;13:319–322.CrossRefGoogle Scholar
Dallman, PR. The red cell. In: Dallman, PR, ed. Blood and Blood-forming Tissues. New York: Appleton-Century-Crofts; 1977:1109–1113.Google Scholar

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×